Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Apr 24, 2012
Par Pharmaceutical Companies, Inc. (NYSE-Listed PRX) visits the NYSE to celebrate the company's 25th anniversary of listing on the NYSE. In honor of the occasion, Chairman and CEO Pat LePore rings The Closing BellSM.
About Par Pharmaceutical Companies, Inc. (NYSE: PRX): Par Pharmaceutical Companies, Inc. is a U.S.-based specialty pharmaceutical company. Through its wholly-owned subsidiary's two operating divisions, Par Pharmaceutical and Strativa Pharmaceuticals, it develops, manufactures and markets higher-barrier-to-entry generic drugs and niche, innovative proprietary pharmaceuticals. For press releases and other company information, visit www.parpharm.com. (Sourced by Par Pharmaceutical Companies, Inc.)